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Introduction
Breast cancer is the most frequent and second leading cause of cancer death in women 1 .
In the majority of cases, the disease is diagnosed at the early stage, when all detectable lesions, confined to the breast or nearby lymph nodes, can be surgically removed 2 .
However, approximately 20-30% of patients are reported to relapse with distant metastases after surgery 3, 4 , suggesting that clinically occult micro-metastases might already be present at the time of surgery. Accurate prediction of the risk of metastatic relapse is critical to personalize adjuvant treatment and avoid use of toxic and costly therapies when not needed.
In the era of artificial intelligence, prognostic models are playing an increasing role for such a task 5 . Online tools, such as the Adjuvant! 6, 7 and PREDICT models 8 , compute
individualized survival probabilities based on multivariate statistical analysis and integration of clinical variables (age, tumor size, histological grade, hormone receptor status and nodal involvement) 5 . These tools, however, are based on agnostic statistical models, such as Cox regression 8, 9 . More recently, machine learning algorithms have started to be used 10 .
Although traditionally designed for classification or regression tasks, adaptations to survival analysis include elastic net for Cox models 11 or the random survival forests algorithm 12 .
Deep learning has also recently been proposed for survival prediction from genomic data sets 13 . Nevertheless, few studies have so far investigated machine learning for prediction of breast cancer survival or recurrence [13] [14] [15] .
Mechanistic modeling approaches -where biological knowledge is used to build a simulation model -have been developed to describe metastatic dynamics [16] [17] [18] [19] [20] . However, none of these mechanistic models has yet been implemented as a personalized predictive tool of metastatic relapse 5 . In previous work, we evaluated a mechanistic model of metastatic development 21 using experimental data from orthosurgical mouse models of breast cancer 22 . The model was able to describe longitudinal growth of the total metastatic burden. For human data, the model could fit size-dependent probability of 20-years metastatic relapse in a historical dataset of 2,648 breast cancer patients 22, 23 .
In the current work, we build on our descriptive model to propose an actionable tool for individualized predictions of the time to metastatic relapse (TTR), as well as reconstruction of the past natural history and prediction of future evolution of the disease. To train and validate the model, we relied on a dataset containing TTR and 21 clinical/pathological characteristics for 642 early-stage breast cancer patients. We first show a random survival forest analysis 12 , which allowed us to select a restricted number of predictors of interest. We then present the main novelty of this work: the calibration -using mixed-effects learning 24 of the mechanistic model. We illustrate the possible value of the mechanistic approach by performing predictive simulations of the entire cancer history of real patients, calibrated from data available at diagnosis only. Finally, we compare our results with predictive performances of classification machine learning algorithms for 5-years metastatic relapse.
Methods

Description of the data
The consisted of data of 642 women diagnosed with primary operable invasive breast carcinoma treated at the Bordeaux Bergonié institute between 1989 and 1993. This dataset has been comprehensively analyzed using standard statistical tools (Cox regression) 25 .
Patients in this analysis did not receive any adjuvant hormone or chemotherapy. Missing covariate values were imputed before model building using the missForest imputation algorithm
27
. The percentage of missing data was less than 5% for all variables ( Figure S1 ). Using 100 trees per forest (predefined setting value of missForest), continuous and categorical covariates were imputed with a 4.4% and 7.1% error, respectively.
Institutional review board approval was obtained for this retrospective study in accordance with national laws.
Random survival forests analysis (RSF)
The RSF algorithm is an extension of Breiman's random forest for the analysis of rightcensored time-to-event data 28 . We utilized the RSF implementation of the randomForestSRC R package
29
. All RSF models were fitted using 1000 trees, with the logrank splitting rule
28
.
The optimal values of the tuning parameters (number of variables to be sampled at each split and minimum number of data points in a terminal node) were selected to maximize the concordance index calculated on the out-of-bag data.
Impact of covariates on the TTR was assessed using the forest-averaged minimal depth 30 , which quantifies the predictive value of a covariate in a tree by its distance from the root node to the first node where it is used to split (smaller minimal depth values correspond to more predictive covariates).
Mechanistic model of metastatic dissemination and growth
The individual primary tumor (PT) kinetics in individual were described by the Gompertz model: . The PT size -reported as a diameter in the data -was converted into number of cells assuming spherical shape and the assumption 1mm @ = 10 A cells 31, 32 . All model simulations were performed in number of cells.
Considering a dissemination rate from the PT given by
the total number of metastases at time is
The individual parameter & is the per day probability for a PT cell to disseminate and establish a distant metastatic colony. Each metastasis was assumed to start from the volume J of a single cell and to grow at the same rate than the PT:
The state of the metastatic process was described by a function 
Mechanistic modeling of the time-to-relapse
To calibrate the metastatic model on TTR data, we defined the theoretical time to relapse as illustrated in Figure 1 . More precisely, assuming a value V&Y as detection threshold, the time V&Y for a tumor to reach this size was given from the assumption of Gompertzian growth, i.e.
In an analogous way, the time from the first cancer cell to the detection of the primary tumor, A visibility threshold V&Y of 5 mm in diameter was assumed to be the detectability limit at imaging.
Since metastases of size larger than V&Y at time must have been emitted in the time interval C0, − V&Y & D, the number of visible metastases at time can be obtained by
The theoretical TTR was then defined as
That is, the time elapsed from diagnosis to the appearance of the first visible metastasis, if, according to the model, at least a metastasis was emitted before diagnosis; otherwise it was considered as infinite.
Calibration of the mechanistic model using mixed-effects learning A constant error model was assumed on the log-transformed data:
where & is the residual error following a normal distribution with mean 0 and variance > .
The log-transformation was used to ensure positive values of the TTR variable. The individual parameters were assumed to be log-normally distributed and a linear covariate model was used:
where 
where Φ and are the cumulative distribution and probability density functions of the standard normal distribution, respectively. 
Classification machine learning algorithms for prediction of 5-year distant metastasis-free survival
Machine learning algorithms were trained using the scikit-learn python package Each model was evaluated using 100 replicates of 10-fold cross-validations, with folds created using a stratified random sampling strategy (to preserve class balance). We applied a standard scaling for each run and each set by removing the training folds mean and scaling to unit variance, for the algorithms that require a homogeneous scale (SVM, kNN). The random forests algorithm was also seeded with a different random initialization value each time.
Evaluation of predictive performances
All models were internally validated using 10-fold cross-validation. For classification tasks, the models were evaluated using receiver operating characteristic (ROC) curve analysis and standard performance metrics for binary classification algorithms 
Results
Random survival forest multivariate analysis
For machine learning analysis of the TTR data, we used the RSF algorithm, which allows right-censored data 30 . In addition to evaluating its predictive power, we used this algorithm to identify variables most predictive of TTR. Covariates were ordered on the basis of minimal depth ( Partial dependence plots for the selected covariates indicated strong nonlinear relationships between covariates and relapse probabilities, with a non-monotonic behavior for age and tumor size ( Figure S2 ). Confirming previous results
38
, these plots suggest nonvalidity of the proportional hazards assumption. Indeed, if such assumption would hold, the probability of no relapse at any time would be monotonous as a function of any covariate value.
Calibration and validation of the mechanistic model
To offer better insights on the mechanisms of relapse, we developed a mechanistic model of the TTR. We first evaluated the ability of this model to describe the TTR data without using covariates, except for pathological tumor size, which is a variable encoded in the structural model. We asked whether we could describe inter-individual variability of TTR by means of population statistical distributions of the parameters (dissemination) and (growth) of the model. Estimates of the population parameters were obtained using the SAEM algorithm and are reported in Table 1 . Both fixed and random effects were identified with satisfactory precision (relative standard error < 37%). Figure 3A 
Mechanistic covariate analysis and predictive power of the mathematical model
We next tested the covariates selected by the RSF analysis in the mechanistic model. We built the covariate model using a backward elimination procedure, starting with the full model with all the preselected covariates on both parameters and . The final model included Ki67 and CD44 on , and EGFR on the dissemination parameter ( Table 1 were obtained between the mechanistic model, the RSF, classification machine learning algorithms and Cox regression ( Table 2) .
Predictive simulations of the mechanistic model
The previous results allow to calibrate the mechanistic model parameters from variables available at diagnosis, by using only the covariate part in equation (2) and neglecting the remaining unexplained variance. We used this to simulate the natural cancer history for a number of representative patients of our dataset. For each patient, the population-level parameters %u% , %u% , Ÿ&A ,, , OE¡¢¢,, and £¤¥¦,} were calibrated from an independent training set that did not contain this patient (coming from the cross-validation procedure).
Simulations were then performed using a discrete version of the metastatic model 22 Table S1 . simulation, the first metastasis in this patient was emitted 2.6 years after the PT onset, i.e.
1.01 years before surgery. The model predicted relapse 1.97 years after diagnosis while true relapse occurred at 3.06 years. The differences in PT and metastatic dynamics for these two patients are due to the different values of the covariates (Table S1 ). Distinct levels of Ki67 cause distinct growth kinetics. Moreover, unlike patient 224, the tumor of patient 358
expresses EGFR, which is associated with a higher metastatic potential. Thus although patient 358's tumor is much younger, the total number of (invisible) metastases at surgery is predicted to be larger (35 vs 21 metastases in patient 224). Model predictions are also informative in the case of individuals who were censored at the last follow-up. For instance, patient 70 ( Figure S4 ) was censored at 17.7 years after diagnosis. This is consistent with our model, which predicts that this patient was disease-free after PT resection and would never have relapsed (TTR = +∞).
Comparison with machine learning classification algorithms and Cox regression
We tested the predictive power of machine learning classification algorithms. These cannot account for right-censored data. Thus, for this part we focused on prediction of 5-years metastatic relapse (yes or no). Best performances were achieved by the random forest and logistic regression models (Table 2 and Figure S5A-D) . However, owing to the low event rate (9.25%), positive predictive value and and F1 scores were low (Table 2 ). To improve these metrics, a balanced, downsampled version of the dataset was constructed. This significantly improved PPV and F1, as well as model calibration ( Figure S5E-F) . We also compared our results to classical Cox regression survival analysis, which was found to exhibit similar predictive power ( Figure S6 , Tables 2 and S2 ).
Discussion
We propose a mechanistic model for prediction of metastatic relapse after surgical intervention in patients with early-stage breast cancer which, for the first time, is able to simulate the pre-and post-diagnosis history of the disease from data available at diagnosis . A recent study that considered recurrence (either local, regional or distant) reported superior predictive power (AUC 0.81 for prediction of relapse at 5-years, versus 0.73 in our analysis), which might be explained by the much larger data set (15, 314 patients) and inclusion of epidemiological data not available in our analysis. ).
Our analysis also confirmed the prognostic value of age at diagnosis, with younger patients having a higher risk of relapse 45 . However, we found that after 60 years-old, the risk of relapse was increasing ( Figure S2 ). This nonlinearity might explain why age did not appear as significant in either our mechanistic or Cox analysis. Although not significant at the 0.05 threshold, our results suggest prognosis value of CD44 (p = 0.083 for association with ).
CD44 is a cellular protein which is used as a marker of breast cancer stem cells 46 . Indeed, the aim of the current study was to establish the methodology of using our mechanistic model as a predictive tool, and we favored first keeping continuous variables. We plan to perform more detailed examination of such clinical variables in forthcoming work, as well as study the predictive power of the model in well-established subgroups such as node-negative patients or patients stratified according to the current molecular classification 50 .
A major advantage and clinical relevance of the mechanistic model over standard statistical or machine learning models, is that it can be used to perform patient-specific simulations allowing to assess the extent of invisible metastases at the time of diagnosis and to predict future growth of metastases. In turn, this might aid selecting patients that will most benefit from extended adjuvant therapy (or conversely, patients who would need only a limited number of cycles), by performing individualized simulations of the future course of the disease under competing therapeutic strategies. However, it will be first required to develop and validate models integrating the effect of systemic adjuvant therapies
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. We also believe that our methodology could be applied to other cancer types where similar concerns occur about the use of adjuvant therapy to avoid metastatic relapse (e.g. lung or kidney cancer).
In addition, the novel approach we propose to mechanistically model time-to-event data could be used to extract biologically relevant information from such data, which -although ubiquitous in clinical oncology -are almost exclusively analyzed using agnostic statistical tools.
Our model represents a first attempt of a mechanistic, individual-level, predictive model of metastatic relapse and might be improved in a number of ways. For instance, unexplained variability remained important despite the inclusion of covariates, suggesting that biomarkers other than those tested might improve model predictions. In this regard, genetic expression signatures have been shown to have higher predictive power compared to standard histological and clinical variables alone 52 . Our mechanistic model could also be refined by higher order phenomena such as dormancy, which has been proposed to explain recurrence occurring after many years from surgery 53, 54 . Finally, to be applied in clinical practice, the model should be further evaluated on external data sets. For comparison purpose between time-to-event and classification models, prediction metrics performed on the entire data set are reported. In bold is the best score achieved for a given metric. 
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